BCRX logo

BioCryst Pharmaceuticals (BCRX) Current assets

annual current assets:

$421.97M-$74.00M(-14.92%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BCRX annual total current assets is $421.97 million, with the most recent change of -$74.00 million (-14.92%) on December 31, 2024.
  • During the last 3 years, BCRX annual current assets has fallen by -$144.17 million (-25.47%).
  • BCRX annual current assets is now -25.47% below its all-time high of $566.14 million, reached on December 31, 2021.

Performance

BCRX Current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

quarterly current assets:

$409.98M-$11.99M(-2.84%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BCRX quarterly total current assets is $409.98 million, with the most recent change of -$11.99 million (-2.84%) on March 31, 2025.
  • Over the past year, BCRX quarterly current assets has dropped by -$37.12 million (-8.30%).
  • BCRX quarterly current assets is now -27.58% below its all-time high of $566.14 million, reached on December 31, 2021.

Performance

BCRX quarterly current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Current assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

BCRX Current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-14.9%-8.3%
3 y3 years-25.5%-19.9%
5 y5 years+156.8%+226.7%

BCRX Current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-25.5%at low-20.6%+12.8%
5 y5-year-25.5%+156.8%-27.6%+226.7%
alltimeall time-25.5%+3701.5%-27.6%+4961.4%

BCRX Current assets History

DateAnnualQuarterly
Mar 2025
-
$409.98M(-2.8%)
Dec 2024
$68.45M(+226.1%)
$421.97M(-1.2%)
Sep 2024
-
$427.13M(+17.5%)
Jun 2024
-
$363.46M(-18.7%)
Mar 2024
-
$447.10M(-9.9%)
Dec 2023
$20.99M(-37.3%)
$495.97M(-1.3%)
Sep 2023
-
$502.47M(-1.7%)
Jun 2023
-
$511.06M(+4.1%)
Mar 2023
-
$490.88M(-5.0%)
Dec 2022
$33.50M(+52.2%)
$516.50M(+1.5%)
Sep 2022
-
$509.00M(+2.9%)
Jun 2022
-
$494.85M(-3.3%)
Mar 2022
-
$511.71M(-9.6%)
Dec 2021
$22.02M(+101.7%)
$566.14M(+124.0%)
Sep 2021
-
$252.74M(-4.9%)
Jun 2021
-
$265.80M(-2.9%)
Mar 2021
-
$273.77M(-15.5%)
Dec 2020
$10.91M(-0.2%)
$323.80M(+99.3%)
Sep 2020
-
$162.44M(-20.3%)
Jun 2020
-
$203.84M(+62.4%)
Mar 2020
-
$125.51M(-23.6%)
Dec 2019
$10.94M(-66.3%)
$164.34M(+108.6%)
Sep 2019
-
$78.80M(-24.0%)
Jun 2019
-
$103.72M(-11.8%)
Mar 2019
-
$117.65M(+2.9%)
Dec 2018
$32.49M(-38.5%)
$114.35M(-11.0%)
Sep 2018
-
$128.50M(+38.7%)
Jun 2018
-
$92.67M(-11.0%)
Mar 2018
-
$104.16M(-16.9%)
Dec 2017
$52.87M(+131.3%)
$125.39M(-28.5%)
Sep 2017
-
$175.37M(+90.1%)
Jun 2017
-
$92.26M(-18.7%)
Mar 2017
-
$113.50M(+69.4%)
Dec 2016
$22.86M(-61.0%)
$66.99M(+3.6%)
Sep 2016
-
$64.63M(+40.2%)
Jun 2016
-
$46.11M(-8.6%)
Mar 2016
-
$50.42M(-21.0%)
Dec 2015
$58.56M(+23.2%)
$63.79M(-24.5%)
Sep 2015
-
$84.50M(-21.1%)
Jun 2015
-
$107.09M(+31.6%)
Mar 2015
-
$81.37M(-8.9%)
Dec 2014
$47.53M(+604.7%)
$89.34M(-33.9%)
Sep 2014
-
$135.14M(-2.2%)
Jun 2014
-
$138.25M(+286.9%)
Mar 2014
-
$35.73M(-15.2%)
Dec 2013
$6.75M(-56.4%)
$42.12M(-10.1%)
Sep 2013
-
$46.84M(+39.7%)
Jun 2013
-
$33.53M(-5.3%)
Mar 2013
-
$35.41M(-15.7%)
Dec 2012
$15.46M(-47.3%)
$41.98M(-9.9%)
Sep 2012
-
$46.58M(+3.4%)
Jun 2012
-
$45.06M(-14.9%)
Mar 2012
-
$52.95M(+0.2%)
Dec 2011
$29.35M(+33.2%)
$52.86M(-12.6%)
Sep 2011
-
$60.45M(-24.3%)
Jun 2011
-
$79.88M(-20.5%)
Mar 2011
-
$100.45M(+14.9%)
Dec 2010
$22.03M(-29.3%)
$87.42M(-2.6%)
Sep 2010
-
$89.76M(+12.5%)
Jun 2010
-
$79.75M(-14.0%)
Mar 2010
-
$92.79M(-16.4%)
Dec 2009
$31.17M
$111.02M(+119.0%)
DateAnnualQuarterly
Sep 2009
-
$50.69M(-11.8%)
Jun 2009
-
$57.45M(-11.8%)
Mar 2009
-
$65.13M(-13.2%)
Dec 2008
$9.67M(-81.0%)
$75.02M(-6.3%)
Sep 2008
-
$80.11M(+44.0%)
Jun 2008
-
$55.62M(-28.0%)
Mar 2008
-
$77.26M(-15.8%)
Dec 2007
$51.01M(+124.8%)
$91.70M(+0.2%)
Sep 2007
-
$91.56M(+78.0%)
Jun 2007
-
$51.43M(+8.8%)
Mar 2007
-
$47.29M(+3.3%)
Dec 2006
$22.70M(+25.1%)
$45.79M(-5.9%)
Sep 2006
-
$48.66M(-20.6%)
Jun 2006
-
$61.25M(-14.7%)
Mar 2006
-
$71.79M(-11.5%)
Dec 2005
$18.15M(+111.1%)
$81.10M(+157.6%)
Sep 2005
-
$31.48M(-6.8%)
Jun 2005
-
$33.79M(-19.0%)
Mar 2005
-
$41.71M(+74.7%)
Dec 2004
$8.60M(-8.5%)
$23.87M(+1.5%)
Sep 2004
-
$23.52M(-4.8%)
Jun 2004
-
$24.70M(-15.1%)
Mar 2004
-
$29.09M(+40.5%)
Dec 2003
$9.39M(-42.6%)
$20.70M(+2.6%)
Sep 2003
-
$20.17M(-22.6%)
Jun 2003
-
$26.08M(+10.7%)
Mar 2003
-
$23.56M(-5.5%)
Dec 2002
$16.37M(-38.7%)
$24.93M(-10.6%)
Sep 2002
-
$27.88M(+0.5%)
Jun 2002
-
$27.73M(-7.5%)
Mar 2002
-
$29.98M(-7.5%)
Dec 2001
$26.69M(-40.8%)
$32.40M(+2.5%)
Sep 2001
-
$31.63M(-4.5%)
Jun 2001
-
$33.10M(-2.9%)
Mar 2001
-
$34.08M(+32.3%)
Dec 2000
$45.07M(-7.7%)
$25.76M(-2.6%)
Sep 2000
-
$26.45M(-2.6%)
Jun 2000
-
$27.15M(-0.9%)
Mar 2000
-
$27.40M(+11.4%)
Dec 1999
$48.80M(+687.1%)
$24.60M(+23.0%)
Sep 1999
-
$20.00M(+9.9%)
Jun 1999
-
$18.20M(-6.2%)
Mar 1999
-
$19.40M(-15.3%)
Dec 1998
$6.20M(-8.8%)
$22.90M(0.0%)
Sep 1998
-
$22.90M(+16.8%)
Jun 1998
-
$19.60M(-4.4%)
Mar 1998
-
$20.50M(+4.1%)
Dec 1997
$6.80M(-24.4%)
$19.70M(-21.5%)
Sep 1997
-
$25.10M(-11.0%)
Jun 1997
-
$28.20M(+20.0%)
Mar 1997
-
$23.50M(-16.4%)
Dec 1996
$9.00M(+542.9%)
$28.10M(-17.8%)
Sep 1996
-
$34.20M(+85.9%)
Jun 1996
-
$18.40M(+3.4%)
Mar 1996
-
$17.80M(+52.1%)
Dec 1995
$1.40M(-17.6%)
$11.70M(-12.7%)
Sep 1995
-
$13.40M(-13.0%)
Jun 1995
-
$15.40M(+90.1%)
Mar 1995
-
$8.10M(-27.0%)
Dec 1994
$1.70M
$11.10M(-14.6%)
Sep 1994
-
$13.00M(-1.5%)
Jun 1994
-
$13.20M(+3.9%)
Mar 1994
-
$12.70M

FAQ

  • What is BioCryst Pharmaceuticals annual total current assets?
  • What is the all time high annual current assets for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual current assets year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly total current assets?
  • What is the all time high quarterly current assets for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly current assets year-on-year change?

What is BioCryst Pharmaceuticals annual total current assets?

The current annual current assets of BCRX is $421.97M

What is the all time high annual current assets for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual total current assets is $566.14M

What is BioCryst Pharmaceuticals annual current assets year-on-year change?

Over the past year, BCRX annual total current assets has changed by -$74.00M (-14.92%)

What is BioCryst Pharmaceuticals quarterly total current assets?

The current quarterly current assets of BCRX is $409.98M

What is the all time high quarterly current assets for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly total current assets is $566.14M

What is BioCryst Pharmaceuticals quarterly current assets year-on-year change?

Over the past year, BCRX quarterly total current assets has changed by -$37.12M (-8.30%)
On this page